ClinicalTrials.gg
Not yet recruitingNCT07910253Updated Nov 2, 2026

Deep-plane Facelift As A Staged Adjunct To Facial Reanimation : Functional And Aesthetic Outcomes in Comparison to Facial Reanimation Alone

An interventional study of Facial reanimation in patients with facial palsy without deep plane facelift. and Deep plane facelift adjunct to facial reanimation in Group 2 in Facial Palsy, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Assiut University · Not applicable, Interventional, and Treatment

Updated Nov 2, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
4
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Long-standing unilateral facial paralysis is a complex functional and aesthetic disorder characterized by impaired facial movement, static asymmetry, and progressive soft-tissue changes. Chronic muscular imbalance and loss of tone may result in malar descent, distortion of the nasolabial fold, oral commissure malposition, jowling, reduced mandibular definition, and asymmetric facial aging. These deformities may persist despite successful dynamic facial reanimation.

Contemporary reanimation procedures, including masseteric-to-facial nerve transfer, cross-face nerve grafting, free functional muscle transfer, and temporalis transfer, can restore facial movement and improve dynamic symmetry. However, restoration of motor function does not necessarily correct residual static soft-tissue ptosis or asymmetry. Therefore, a staged approach addressing both dynamic function and static facial contour may be beneficial.

Deep-plane facelift techniques allow repositioning of the facial soft-tissue envelope through deep-plane mobilization and release of retaining ligaments. Their application in facial paralysis has recently been explored, but limited evidence exists regarding their use as a secondary procedure following established dynamic facial reanimation.

Comprehensive outcome assessment should incorporate clinician-reported, patient-reported, and objective measures. The eFACE and Facial Clinimetric Evaluation (FaCE) Scale provide complementary assessments of facial function and patient-perceived disability, while FACE-Q instruments can evaluate aesthetic and psychosocial outcomes.

Accordingly, this prospective study evaluates deep-plane facelift as a staged adjunct after stable facial reanimation, focusing on improvement in static facial symmetry and patient-perceived appearance while maintaining previously restored dynamic facial function.

02

Conditions studied

  • Facial Palsy

Browse trials for

Keywords

  • facial reanimation ,deep plane facelift ,facial palsy
03

In context

Facial Paralysis

81 studies on the registry are indexed under Facial Paralysis; 28 are open to participants now.

This study's planned enrollment of 4 is below the median of 50 across 59 interventional studies indexed under Facial Paralysis.

Browse Facial Paralysis studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 1.Age ≥18 years. 2.Unilateral facial palsy (paralysis and pareses). 3.Previous first stage facial reanimation. 4.Persistent static facial asymmetry 5.Presence of at least one of the following:

    • malar descent;
    • oral commissure descent;
    • lower-face soft-tissue ptosis;
    • asymmetric nasolabial fold;
    • jowling;
    • loss of mandibular definition;
    • asymmetric facial aging.

Exclusion criteria

Exclusion Criteria:

- 1-acute facial paralysis. 2-ongoing spontaneous neurological recovery. 3-previous extensive facelift surgery significantly altering deep-plane anatomy.

4-active facial infection. 5-uncontrolled systemic disease that substantially increases surgical risk. 6-conditions associated with impaired wound healing. 7-inability to comply with perioperative smoking cessation where required.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
4 participants (estimated)

Study arms

  • Experimental
    Group 1 (control group )

    Facial reanimation in patients with facial palsy without deep plane facelift .

    Procedure: Facial reanimation in patients with facial palsy without deep plane facelift.

  • Experimental
    Group 2

    Deep plane facelift adjunct to facial reanimation

    Procedure: Deep plane facelift adjunct to facial reanimation in Group 2

Interventions

  • ProcedureFacial reanimation in patients with facial palsy without deep plane facelift.

    Facial reanimation in patients with facial palsy without deep plane facelift . The exact procedure will be documented in facial reanimation , including: 1. masseteric-to-facial nerve transfer. 2. cross-face nerve graft. 3. hypoglossal-facial nerve transfer. 4. free functional muscle transfer. 5. temporalis muscle transfer. 6. combined reanimation.

  • ProcedureDeep plane facelift adjunct to facial reanimation in Group 2

    Deep plane facelift adjunct to facial reanimation.

06

What researchers measure

Primary outcomes

  1. A multidimensional outcome framework will be used incorporating: 1. Clinician-reported facial function eFACE

    Time frame: 6 months

Secondary outcomes

  1. Objective quantitative facial symmetry Standardized digital photography/video analysis

    Time frame: 6 months

07

Study locations

No study locations are listed for this record.

08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07910253
Lead sponsor
Assiut University
Responsible party
Ibrahim Ragab Ibrahim ali (Assistant lecturer of plastic surgery, Assiut University) — Principal investigator
First posted
Nov 2, 2026
Start date
Dec 2026 (estimated)
Primary completion
Dec 2028 (estimated)
Completion
Jun 2029 (estimated)
Last update
Nov 2, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion